Login to Your Account

Deals And M&A NEWS

"People were surprised [by the deal] because we had been making a lot of progress and moving quickly [on our own]," Wave Life Sciences Ltd. CEO Paul Bolno told BioWorld, talking about the arrangement disclosed this week with Takeda Pharmaceutical Co. Ltd., a pact "very much aligned with our strategy, which is growth to becoming a fully integrated company."

Voyager Therapeutics Inc. struck another big pharma partnership for its gene therapy platform, attracting Abbvie Inc. to a strategic collaboration and option agreement to develop and commercialize vectorized antibodies against tau in Alzheimer's disease (AD) and other neurodegenerative diseases.

PERTH, Australia – Allergan plc is acquiring Sydney-based Elastagen Pty Ltd., a private company with a tissue repair platform that complements Allergan's aesthetic and dermatology franchise.

More Deals And M&A Headlines

Cast Your Vote

Should there be restrictions on the use of gene-editing technology?: